Analysts See 28.2% Upside for Onto Innovation with $252.50 Mean Target
Onto Innovation closed the latest session at $196.89, rising 4.3% over the past four weeks, and carries a mean analyst price target of $252.50, suggesting 28.2% upside potential. Analysts' eight short-term targets show a $44 standard deviation, ranging from a $160 low (18.7% downside) to a $300 high (52.4% upside).
1. Consensus Price Target
Eight short-term analyst targets yield a mean of $252.50 with a standard deviation of $44, reflecting moderate agreement on Onto Innovation’s valuation outlook.
2. Upside and Downside Potential
The lowest target of $160 implies an 18.7% decline from current levels, while the most optimistic outlook of $300 suggests a 52.4% increase, framing a wide range for risk and reward.
3. Earnings Estimate Revisions
Analysts have raised Onto Innovation’s full-year EPS estimates by 5.6% over the past month, with four upward revisions and none downward, bolstering confidence in its near-term earnings trajectory. Its current rank #2 (Buy) places it in the top quintile of coverage.
4. Caution on Price Targets
Historical data indicates that price targets often overstate outcomes due to business incentives and optimism bias, underscoring the importance of combining target data with fundamental analysis and market conditions before making investment decisions.